SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-255508
Filing Date
2022-09-30
Accepted
2022-09-30 16:11:56
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d380143ds3.htm S-3 453008
2 EX-1.2 d380143dex12.htm EX-1.2 197605
3 EX-4.5 d380143dex45.htm EX-4.5 284330
4 EX-4.8 d380143dex48.htm EX-4.8 92862
5 EX-4.9 d380143dex49.htm EX-4.9 95538
6 EX-4.10 d380143dex410.htm EX-4.10 82397
7 EX-5.1 d380143dex51.htm EX-5.1 30484
8 EX-23.1 d380143dex231.htm EX-23.1 1625
9 EX-FILING FEES d380143dexfilingfees.htm EX-FILING FEES 40257
10 GRAPHIC g380143g04h00.jpg GRAPHIC 40943
11 GRAPHIC g380143g0928020539854.jpg GRAPHIC 2584
  Complete submission text file 0001193125-22-255508.txt   1339343
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267674 | Film No.: 221284167
SIC: 2834 Pharmaceutical Preparations